Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. September 2025 08:05 ET | Quelle: Quotient Therapeutics, Inc.

Quotient Therapeutics Appoints Drug Discovery and Development Veteran, Andrew Bayliffe, as Chief Development Officer

CAMBRIDGE, Mass., and CAMBRIDGE, United Kingdom, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced...
07. November 2024 07:30 ET | Quelle: Quotient Therapeutics, Inc.

Quotient Therapeutics Appoints Sir Mene Pangalos, Ph.D. to Board of Directors

CAMBRIDGE, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Quotient Therapeutics, a company pioneering somatic genomics, today announced the appointment of Sir Mene Pangalos, Ph.D., to the company’s Board...
07. August 2024 07:30 ET | Quelle: Quotient Therapeutics, Inc.

Quotient Therapeutics Appoints Peter Campbell, Ph.D. as Chief Scientific Officer

CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Quotient Therapeutics, a company pioneering somatic genomics, today announced the appointment of the company’s academic co-founder from the...